APO Research

APO RESEARCH · REPORT

Automated and Rapid Microbiological Tests Bussiness

Selected research

Market Analysis & Forecast

Global Automated and Rapid Microbiological Tests Bussiness Market Analysis and Forecast 2026-2032

Market perspective

The global Automated and Rapid Microbiological Tests Bussiness market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Automated and Rapid Microbiological Tests Bussiness is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Automated and Rapid Microbiological Tests Bussiness is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Automated and Rapid Microbiological Tests Bussiness is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Automated and Rapid Microbiological Tests Bussiness is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Automated and Rapid Microbiological Tests Bussiness include Thermo Fisher Scientific, Roche, Siemens Healthcare Diagnostics, Sekisui Diagnostics, Remel, Quidel Corporation, Oxoid Limited, Orion Diagnostica Oy and Orasure Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Automated and Rapid Microbiological Tests Bussiness, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Automated and Rapid Microbiological Tests Bussiness, also provides the revenue of main regions and countries. Of the upcoming market potential for Automated and Rapid Microbiological Tests Bussiness, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Automated and Rapid Microbiological Tests Bussiness revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Automated and Rapid Microbiological Tests Bussiness market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Automated and Rapid Microbiological Tests Bussiness revenue, projected growth trends, production technology, application and end-user industry.

Automated and Rapid Microbiological Tests Bussiness Segment by Company

Thermo Fisher Scientific

Roche

Siemens Healthcare Diagnostics

Sekisui Diagnostics

Remel

Quidel Corporation

Oxoid Limited

Orion Diagnostica Oy

Orasure Technologies

Meridian Biosciences

MedMira

Gen-Probe

Celsis International

Cellabs

Bio-Rad Laboratories

BioMerieux SA

Becton Dickinson and Company

Abbott Laboratories

Automated and Rapid Microbiological Tests Bussiness Segment by Type

Automated Identification & Susceptibility Systems

Automated Tuberculosis Systems

Automated Blood Culture Systems

Streptococcal Infection Rapid Tests

GC/Chlamydia Rapid Tests

Other

Automated and Rapid Microbiological Tests Bussiness Segment by Application

Clinical

Non-Clinical

Automated and Rapid Microbiological Tests Bussiness Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated and Rapid Microbiological Tests Bussiness market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automated and Rapid Microbiological Tests Bussiness and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated and Rapid Microbiological Tests Bussiness.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Automated and Rapid Microbiological Tests Bussiness in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Automated and Rapid Microbiological Tests Bussiness company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Automated and Rapid Microbiological Tests Bussiness revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Automated Identification & Susceptibility Systems Major Player Table 3. Automated Tuberculosis Systems Major Player Table 4. Automated Blood Culture Systems Major Player Table 5. Streptococcal Infection Rapid Tests Major Player Table 6. GC/Chlamydia Rapid Tests Major Player Table 7. Other Major Player Table 8. Global Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Clinical Major Player Table 10. Non-Clinical Major Player Table 11. Automated and Rapid Microbiological Tests Bussiness Industry Trends Table 12. Automated and Rapid Microbiological Tests Bussiness Industry Drivers Table 13. Automated and Rapid Microbiological Tests Bussiness Industry Opportunities and Challenges Table 14. Automated and Rapid Microbiological Tests Bussiness Industry Restraints Table 15. Global Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Automated and Rapid Microbiological Tests Bussiness Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Automated and Rapid Microbiological Tests Bussiness Market Share by Region (2021-2026) Table 18. Global Automated and Rapid Microbiological Tests Bussiness Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Automated and Rapid Microbiological Tests Bussiness Market Share by Region (2027-2032) Table 20. Global Automated and Rapid Microbiological Tests Bussiness Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Players (2021-2026) Table 22. Global Automated and Rapid Microbiological Tests Bussiness Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Automated and Rapid Microbiological Tests Bussiness Key Players Headquarters & Area Served Table 24. Global Automated and Rapid Microbiological Tests Bussiness Players, Product Type & Application Table 25. Global Automated and Rapid Microbiological Tests Bussiness Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Automated and Rapid Microbiological Tests Bussiness by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Automated and Rapid Microbiological Tests Bussiness Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Type (2021-2026) Table 32. Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Type (2027-2032) Table 33. Global Automated and Rapid Microbiological Tests Bussiness Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Application (2021-2026) Table 37. Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Application (2027-2032) Table 38. Thermo Fisher Scientific Company Information Table 39. Thermo Fisher Scientific Business Overview Table 40. Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 42. Thermo Fisher Scientific Recent Development Table 43. Roche Company Information Table 44. Roche Business Overview Table 45. Roche Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Roche Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 47. Roche Recent Development Table 48. Siemens Healthcare Diagnostics Company Information Table 49. Siemens Healthcare Diagnostics Business Overview Table 50. Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 52. Siemens Healthcare Diagnostics Recent Development Table 53. Sekisui Diagnostics Company Information Table 54. Sekisui Diagnostics Business Overview Table 55. Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 57. Sekisui Diagnostics Recent Development Table 58. Remel Company Information Table 59. Remel Business Overview Table 60. Remel Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Remel Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 62. Remel Recent Development Table 63. Quidel Corporation Company Information Table 64. Quidel Corporation Business Overview Table 65. Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 67. Quidel Corporation Recent Development Table 68. Oxoid Limited Company Information Table 69. Oxoid Limited Business Overview Table 70. Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 72. Oxoid Limited Recent Development Table 73. Orion Diagnostica Oy Company Information Table 74. Orion Diagnostica Oy Business Overview Table 75. Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 77. Orion Diagnostica Oy Recent Development Table 78. Orasure Technologies Company Information Table 79. Orasure Technologies Business Overview Table 80. Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 82. Orasure Technologies Recent Development Table 83. Meridian Biosciences Company Information Table 84. Meridian Biosciences Business Overview Table 85. Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 87. Meridian Biosciences Recent Development Table 88. MedMira Company Information Table 89. MedMira Business Overview Table 90. MedMira Automated and Rapid Microbiological Tests Bussiness Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. MedMira Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 92. MedMira Recent Development Table 93. Gen-Probe Company Information Table 94. Gen-Probe Business Overview Table 95. Gen-Probe Automated and Rapid Microbiological Tests Bussiness Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Gen-Probe Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 97. Gen-Probe Recent Development Table 98. Celsis International Company Information Table 99. Celsis International Business Overview Table 100. Celsis International Automated and Rapid Microbiological Tests Bussiness Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Celsis International Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 102. Celsis International Recent Development Table 103. Cellabs Company Information Table 104. Cellabs Business Overview Table 105. Cellabs Automated and Rapid Microbiological Tests Bussiness Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Cellabs Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 107. Cellabs Recent Development Table 108. Bio-Rad Laboratories Company Information Table 109. Bio-Rad Laboratories Business Overview Table 110. Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 112. Bio-Rad Laboratories Recent Development Table 113. BioMerieux SA Company Information Table 114. BioMerieux SA Business Overview Table 115. BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 117. BioMerieux SA Recent Development Table 118. Becton Dickinson and Company Company Information Table 119. Becton Dickinson and Company Business Overview Table 120. Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 122. Becton Dickinson and Company Recent Development Table 123. Abbott Laboratories Company Information Table 124. Abbott Laboratories Business Overview Table 125. Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 127. Abbott Laboratories Recent Development Table 128. North America Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2026) & (US$ Million) Table 129. North America Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2027-2032) & (US$ Million) Table 130. North America Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. North America Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021-2026) & (US$ Million) Table 134. North America Automated and Rapid Microbiological Tests Bussiness Revenue by Country (US$ Million) & (2027-2032) Table 135. Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Country (US$ Million) & (2027-2032) Table 142. China Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2026) & (US$ Million) Table 143. China Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2027-2032) & (US$ Million) Table 144. China Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2026) & (US$ Million) Table 145. China Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Region (US$ Million) & (2021-2026) Table 152. Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Region (US$ Million) & (2027-2032) Table 153. SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2026) & (US$ Million) Table 156. SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2027-2032) & (US$ Million) Table 157. SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021-2026) & (US$ Million) Table 159. SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Country (US$ Million) & (2027-2032) Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Automated and Rapid Microbiological Tests Bussiness Image Figure 2. Global Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Automated and Rapid Microbiological Tests Bussiness Market Size Share 2021 VS 2025 VS 2032 Figure 4. Automated Identification & Susceptibility Systems Image Figure 5. Automated Tuberculosis Systems Image Figure 6. Automated Blood Culture Systems Image Figure 7. Streptococcal Infection Rapid Tests Image Figure 8. GC/Chlamydia Rapid Tests Image Figure 9. Other Image Figure 10. Global Automated and Rapid Microbiological Tests Bussiness Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Automated and Rapid Microbiological Tests Bussiness Market Size Share 2021 VS 2025 VS 2032 Figure 12. Clinical Image Figure 13. Non-Clinical Image Figure 14. Global Automated and Rapid Microbiological Tests Bussiness Market Size (US$ Million) & (2021-2032) Figure 15. Global Automated and Rapid Microbiological Tests Bussiness Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Automated and Rapid Microbiological Tests Bussiness Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Automated and Rapid Microbiological Tests Bussiness Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Type (2021-2032) Figure 22. Global Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Application (2021-2032) Figure 25. North America Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Automated and Rapid Microbiological Tests Bussiness Revenue Share by Type (2021-2032) Figure 27. North America Automated and Rapid Microbiological Tests Bussiness Revenue Share by Application (2021-2032) Figure 28. North America Automated and Rapid Microbiological Tests Bussiness Revenue Share by Country (2021-2032) Figure 29. United States Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Automated and Rapid Microbiological Tests Bussiness Revenue Share by Type (2021-2032) Figure 34. Europe Automated and Rapid Microbiological Tests Bussiness Revenue Share by Application (2021-2032) Figure 35. Europe Automated and Rapid Microbiological Tests Bussiness Revenue Share by Country (2021-2032) Figure 36. Germany Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Automated and Rapid Microbiological Tests Bussiness Revenue Share by Type (2021-2032) Figure 46. China Automated and Rapid Microbiological Tests Bussiness Revenue Share by Application (2021-2032) Figure 47. Asia Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Automated and Rapid Microbiological Tests Bussiness Revenue Share by Type (2021-2032) Figure 49. Asia Automated and Rapid Microbiological Tests Bussiness Revenue Share by Application (2021-2032) Figure 50. Asia Automated and Rapid Microbiological Tests Bussiness Revenue Share by Region (2021-2032) Figure 51. Japan Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue Share by Type (2021-2032) Figure 59. SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue Share by Application (2021-2032) Figure 60. SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue Share by Country (2021-2032) Figure 61. Brazil Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Automated and Rapid Microbiological Tests Bussiness Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Automated Identification & Susceptibility Systems
  • Automated Tuberculosis Systems
  • Automated Blood Culture Systems
  • Streptococcal Infection Rapid Tests
  • GC/Chlamydia Rapid Tests
  • Other
Applications
  • Clinical
  • Non-Clinical
Companies covered
  • Thermo Fisher Scientific
  • Roche
  • Siemens Healthcare Diagnostics
  • Sekisui Diagnostics
  • Remel
  • Quidel Corporation
  • Oxoid Limited
  • Orion Diagnostica Oy
  • Orasure Technologies
  • Meridian Biosciences
  • MedMira
  • Gen-Probe
  • Celsis International
  • Cellabs
  • Bio-Rad Laboratories
  • BioMerieux SA
  • Becton Dickinson and Company
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Automated and Rapid Microbiological Tests Bussiness Market by Type
  3. 1.2.1 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Automated Identification & Susceptibility Systems
  5. 1.2.3 Automated Tuberculosis Systems
  6. 1.2.4 Automated Blood Culture Systems
  7. 1.2.5 Streptococcal Infection Rapid Tests
  8. 1.2.6 GC/Chlamydia Rapid Tests
  9. 1.2.7 Other
  10. 1.3 Automated and Rapid Microbiological Tests Bussiness Market by Application
  11. 1.3.1 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Clinical
  13. 1.3.3 Non-Clinical
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Automated and Rapid Microbiological Tests Bussiness Market Dynamics
  1. 2.1 Automated and Rapid Microbiological Tests Bussiness Industry Trends
  2. 2.2 Automated and Rapid Microbiological Tests Bussiness Industry Drivers
  3. 2.3 Automated and Rapid Microbiological Tests Bussiness Industry Opportunities and Challenges
  4. 2.4 Automated and Rapid Microbiological Tests Bussiness Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Automated and Rapid Microbiological Tests Bussiness Market Perspective (2021-2032)
  2. 3.2 Global Automated and Rapid Microbiological Tests Bussiness Growth Trends by Region
  3. 3.2.1 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Region (2021-2026)
  5. 3.2.3 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Automated and Rapid Microbiological Tests Bussiness Revenue by Players
  2. 4.1.1 Global Automated and Rapid Microbiological Tests Bussiness Revenue by Players (2021-2026)
  3. 4.1.2 Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Automated and Rapid Microbiological Tests Bussiness Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Automated and Rapid Microbiological Tests Bussiness Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Automated and Rapid Microbiological Tests Bussiness Key Players Headquarters & Area Served
  7. 4.4 Global Automated and Rapid Microbiological Tests Bussiness Players, Product Type & Application
  8. 4.5 Global Automated and Rapid Microbiological Tests Bussiness Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Automated and Rapid Microbiological Tests Bussiness Market CR5 and HHI
  11. 4.6.3 2025 Automated and Rapid Microbiological Tests Bussiness Tier 1, Tier 2, and Tier 3
5 Automated and Rapid Microbiological Tests Bussiness Market Size by Type
  1. 5.1 Global Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2032)
  3. 5.3 Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Type (2021-2032)
6 Automated and Rapid Microbiological Tests Bussiness Market Size by Application
  1. 6.1 Global Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2032)
  3. 6.3 Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Roche
  8. 7.2.1 Roche Company Information
  9. 7.2.2 Roche Business Overview
  10. 7.2.3 Roche Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Roche Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  12. 7.2.5 Roche Recent Developments
  13. 7.3 Siemens Healthcare Diagnostics
  14. 7.3.1 Siemens Healthcare Diagnostics Company Information
  15. 7.3.2 Siemens Healthcare Diagnostics Business Overview
  16. 7.3.3 Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  18. 7.3.5 Siemens Healthcare Diagnostics Recent Developments
  19. 7.4 Sekisui Diagnostics
  20. 7.4.1 Sekisui Diagnostics Company Information
  21. 7.4.2 Sekisui Diagnostics Business Overview
  22. 7.4.3 Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  24. 7.4.5 Sekisui Diagnostics Recent Developments
  25. 7.5 Remel
  26. 7.5.1 Remel Company Information
  27. 7.5.2 Remel Business Overview
  28. 7.5.3 Remel Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Remel Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  30. 7.5.5 Remel Recent Developments
  31. 7.6 Quidel Corporation
  32. 7.6.1 Quidel Corporation Company Information
  33. 7.6.2 Quidel Corporation Business Overview
  34. 7.6.3 Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  36. 7.6.5 Quidel Corporation Recent Developments
  37. 7.7 Oxoid Limited
  38. 7.7.1 Oxoid Limited Company Information
  39. 7.7.2 Oxoid Limited Business Overview
  40. 7.7.3 Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  42. 7.7.5 Oxoid Limited Recent Developments
  43. 7.8 Orion Diagnostica Oy
  44. 7.8.1 Orion Diagnostica Oy Company Information
  45. 7.8.2 Orion Diagnostica Oy Business Overview
  46. 7.8.3 Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  48. 7.8.5 Orion Diagnostica Oy Recent Developments
  49. 7.9 Orasure Technologies
  50. 7.9.1 Orasure Technologies Company Information
  51. 7.9.2 Orasure Technologies Business Overview
  52. 7.9.3 Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  54. 7.9.5 Orasure Technologies Recent Developments
  55. 7.10 Meridian Biosciences
  56. 7.10.1 Meridian Biosciences Company Information
  57. 7.10.2 Meridian Biosciences Business Overview
  58. 7.10.3 Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  60. 7.10.5 Meridian Biosciences Recent Developments
  61. 7.11 MedMira
  62. 7.11.1 MedMira Company Information
  63. 7.11.2 MedMira Business Overview
  64. 7.11.3 MedMira Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  65. 7.11.4 MedMira Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  66. 7.11.5 MedMira Recent Developments
  67. 7.12 Gen-Probe
  68. 7.12.1 Gen-Probe Company Information
  69. 7.12.2 Gen-Probe Business Overview
  70. 7.12.3 Gen-Probe Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Gen-Probe Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  72. 7.12.5 Gen-Probe Recent Developments
  73. 7.13 Celsis International
  74. 7.13.1 Celsis International Company Information
  75. 7.13.2 Celsis International Business Overview
  76. 7.13.3 Celsis International Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Celsis International Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  78. 7.13.5 Celsis International Recent Developments
  79. 7.14 Cellabs
  80. 7.14.1 Cellabs Company Information
  81. 7.14.2 Cellabs Business Overview
  82. 7.14.3 Cellabs Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cellabs Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  84. 7.14.5 Cellabs Recent Developments
  85. 7.15 Bio-Rad Laboratories
  86. 7.15.1 Bio-Rad Laboratories Company Information
  87. 7.15.2 Bio-Rad Laboratories Business Overview
  88. 7.15.3 Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  90. 7.15.5 Bio-Rad Laboratories Recent Developments
  91. 7.16 BioMerieux SA
  92. 7.16.1 BioMerieux SA Company Information
  93. 7.16.2 BioMerieux SA Business Overview
  94. 7.16.3 BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  96. 7.16.5 BioMerieux SA Recent Developments
  97. 7.17 Becton Dickinson and Company
  98. 7.17.1 Becton Dickinson and Company Company Information
  99. 7.17.2 Becton Dickinson and Company Business Overview
  100. 7.17.3 Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  102. 7.17.5 Becton Dickinson and Company Recent Developments
  103. 7.18 Abbott Laboratories
  104. 7.18.1 Abbott Laboratories Company Information
  105. 7.18.2 Abbott Laboratories Business Overview
  106. 7.18.3 Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  108. 7.18.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Automated and Rapid Microbiological Tests Bussiness Revenue (2021-2032)
  2. 8.2 North America Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2032)
  3. 8.2.1 North America Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2026)
  4. 8.2.2 North America Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2027-2032)
  5. 8.3 North America Automated and Rapid Microbiological Tests Bussiness Revenue Share by Type (2021-2032)
  6. 8.4 North America Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2032)
  7. 8.4.1 North America Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2026)
  8. 8.4.2 North America Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2027-2032)
  9. 8.5 North America Automated and Rapid Microbiological Tests Bussiness Revenue Share by Application (2021-2032)
  10. 8.6 North America Automated and Rapid Microbiological Tests Bussiness Revenue by Country
  11. 8.6.1 North America Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021-2026)
  13. 8.6.3 North America Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Automated and Rapid Microbiological Tests Bussiness Revenue (2021-2032)
  2. 9.2 Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2032)
  3. 9.2.1 Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2026)
  4. 9.2.2 Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2027-2032)
  5. 9.3 Europe Automated and Rapid Microbiological Tests Bussiness Revenue Share by Type (2021-2032)
  6. 9.4 Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2032)
  7. 9.4.1 Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2026)
  8. 9.4.2 Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2027-2032)
  9. 9.5 Europe Automated and Rapid Microbiological Tests Bussiness Revenue Share by Application (2021-2032)
  10. 9.6 Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Country
  11. 9.6.1 Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021-2026)
  13. 9.6.3 Europe Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Automated and Rapid Microbiological Tests Bussiness Revenue (2021-2032)
  2. 10.2 China Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2032)
  3. 10.2.1 China Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2026)
  4. 10.2.2 China Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2027-2032)
  5. 10.3 China Automated and Rapid Microbiological Tests Bussiness Revenue Share by Type (2021-2032)
  6. 10.4 China Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2032)
  7. 10.4.1 China Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2026)
  8. 10.4.2 China Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2027-2032)
  9. 10.5 China Automated and Rapid Microbiological Tests Bussiness Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Automated and Rapid Microbiological Tests Bussiness Revenue (2021-2032)
  2. 11.2 Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2032)
  3. 11.2.1 Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2026)
  4. 11.2.2 Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2027-2032)
  5. 11.3 Asia Automated and Rapid Microbiological Tests Bussiness Revenue Share by Type (2021-2032)
  6. 11.4 Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2032)
  7. 11.4.1 Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2026)
  8. 11.4.2 Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2027-2032)
  9. 11.5 Asia Automated and Rapid Microbiological Tests Bussiness Revenue Share by Application (2021-2032)
  10. 11.6 Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Country
  11. 11.6.1 Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021-2026)
  13. 11.6.3 Asia Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue (2021-2032)
  2. 12.2 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Type (2027-2032)
  5. 12.3 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Application (2027-2032)
  9. 12.5 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Country
  11. 12.6.1 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Automated and Rapid Microbiological Tests Bussiness Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research